Malbrán Will Participate in an International Study on the Childhood Pneumococcal Vaccine

la Nacion

Lean Right

Factuality

Ownership

The Malbrán Institute joined the post-marketing pharmacovigilance study (Phase IV) of the vaccine against 20 pneumococcal serotypes that began to be used progressively since last year with a schedule in children under one year of age instead of the immunizing against 13 serotypes of the bacteria that had been applied. Also participating are centers in the United States, Israel and European countries. The research, according to the National Admin…